1. Home
  2. ARCB vs TARS Comparison

ARCB vs TARS Comparison

Compare ARCB & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ArcBest Corporation

ARCB

ArcBest Corporation

N/A

Current Price

$133.97

Market Cap

2.9B

Sector

Industrials

ML Signal

N/A

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

N/A

Current Price

$77.58

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARCB
TARS
Founded
1923
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.4B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
ARCB
TARS
Price
$133.97
$77.58
Analyst Decision
Buy
Strong Buy
Analyst Count
14
10
Target Price
★ $167.15
$103.44
AVG Volume (30 Days)
222.6K
★ 830.6K
Earning Date
11-04-2026
11-03-2026
Dividend Yield
★ 0.36%
N/A
EPS Growth
N/A
★ 48.21
EPS
★ 1.64
N/A
Revenue
★ $1,657,864,000.00
$451,360,000.00
Revenue This Year
$12.44
$64.28
Revenue Next Year
$7.93
$26.15
P/E Ratio
$82.15
★ N/A
Revenue Growth
12.56
★ 146.71
52 Week Low
$59.43
$53.89
52 Week High
$176.69
$91.53

Technical Indicators

Market Signals
Indicator
ARCB
TARS
Relative Strength Index (RSI) 56.25 59.85
Support Level $133.90 $67.49
Resistance Level $144.77 $80.00
Average True Range (ATR) 5.70 3.69
MACD 0.72 0.86
Stochastic Oscillator 57.35 94.18

Price Performance

Historical Comparison
ARCB
TARS

About ARCB ArcBest Corporation

ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: